Is Piperacillin-Tazobactam Really Comparable to Carbapenem for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?

Clin Infect Dis. 2020 Dec 3;71(9):2539-2540. doi: 10.1093/cid/ciaa115.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carbapenems* / therapeutic use
  • Humans
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination / therapeutic use
  • Pyelonephritis* / drug therapy
  • beta-Lactamases

Substances

  • Carbapenems
  • Piperacillin, Tazobactam Drug Combination
  • beta-Lactamases
  • Piperacillin